| The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria P Hillmen, NS Young, J Schubert, RA Brodsky, G Socié, P Muus, A Röth, ... New England Journal of Medicine 355 (12), 1233-1243, 2006 | 1420 | 2006 |
| Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation R Childs, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, ... New England Journal of Medicine 343 (11), 750-758, 2000 | 1331 | 2000 |
| Current concepts in the pathophysiology and treatment of aplastic anemia NS Young, RT Calado, P Scheinberg Blood 108 (8), 2509-2519, 2006 | 1177 | 2006 |
| Parvovirus B19 NS Young, KE Brown New England Journal of Medicine 350 (6), 586-597, 2004 | 1169 | 2004 |
| Erythrocyte P antigen: cellular receptor for B19 parvovirus KE Brown, SM Anderson, NS Young Science 262 (5130), 114-117, 1993 | 1101 | 1993 |
| Diagnosis and management of paroxysmal nocturnal hemoglobinuria C Parker, M Omine, S Richards, J Nishimura, M Bessler, R Ware, ... Blood 106 (12), 3699-3709, 2005 | 1086 | 2005 |
| Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major GM Brittenham, PM Griffith, AW Nienhuis, CE McLaren, NS Young, ... New England Journal of Medicine 331 (9), 567-573, 1994 | 1059 | 1994 |
| Telomere diseases RT Calado, NS Young New England Journal of Medicine 361 (24), 2353-2365, 2009 | 971 | 2009 |
| Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia H Yamaguchi, RT Calado, H Ly, S Kajigaya, GM Baerlocher, SJ Chanock, ... New England Journal of Medicine 352 (14), 1413-1424, 2005 | 862 | 2005 |
| The pathophysiology of acquired aplastic anemia NS Young, J Maciejewski New England journal of medicine 336 (19), 1365-1372, 1997 | 719 | 1997 |
| Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria P Hillmen, P Muus, U Dührsen, AM Risitano, J Schubert, L Luzzatto, ... Blood, The Journal of the American Society of Hematology 110 (12), 4123-4128, 2007 | 707 | 2007 |
| Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ... Blood, The Journal of the American Society of Hematology 111 (4), 1840-1847, 2008 | 705 | 2008 |
| Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease DB Beck, MA Ferrada, KA Sikora, AK Ombrello, JC Collins, W Pei, ... New England Journal of Medicine 383 (27), 2628-2638, 2020 | 678 | 2020 |
| Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses R Childs, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, ... Blood, The Journal of the American Society of Hematology 94 (9), 3234-3241, 1999 | 676 | 1999 |
| 5-Azacytidine selectively increases γ-globin synthesis in a patient with β+ thalassemia TJ Ley, J DeSimone, NP Anagnou, GH Keller, RK Humphries, PH Turner, ... New England Journal of Medicine 307 (24), 1469-1475, 1982 | 654 | 1982 |
| Somatic mutations and clonal hematopoiesis in aplastic anemia T Yoshizato, B Dumitriu, K Hosokawa, H Makishima, K Yoshida, ... New England Journal of Medicine 373 (1), 35-47, 2015 | 637 | 2015 |
| Why current publication practices may distort science NS Young, JPA Ioannidis, O Al-Ubaydli PLoS medicine 5 (10), e201, 2008 | 623 | 2008 |
| Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in … J Maciejewski, C Selleri, S Anderson, NS Young | 622 | 1995 |
| Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction RV Emmons, DM Reid, RL Cohen, G Meng, NS Young, CE Dunbar, ... | 569 | 1996 |
| Aplastic anemia NS Young New England Journal of Medicine 379 (17), 1643-1656, 2018 | 564 | 2018 |
John BarrettChief Stem Cell Transplant Section, Hematology BranchBestätigte E-Mail-Adresse bei nih.gov
